The state’s medical marijuana advisory board voted Monday morning to allow the sale of whole-plant cannabis — dry leaf and flower — and recommended expanding the number of serious health conditions that would qualify patients to participate in the program.
See our earlier reporting: Pennsylvania Examines Allowing Flower in Medical Marijuana Program
Currently, Pennsylvania allows only for the sale of marijuana oils, extracts, pills, and tinctures.
Pennsylvania Secretary of Health Rachel Levine will weigh the board’s recommendations. She could take up to a year to decide whether to make the changes to the medical marijuana program’s regulations.
Allowing the sale of leaf and flower could reduce the cost of the medicine for patients, many of whom have recoiled at the steep prices and limited selection of processed marijuana products for sale at dispensaries.
Top photo courtesy of Adobe Stock
